[en] BACKGROUND AND PURPOSE: The recent RTOG guidelines for future clinical developments in gynecologic malignancies included the investigation of dose escalation in the paraaortic (PO) region which is, however, very difficult to target due to the presence of critical organs such as kidneys, liver, spinal cord, and digestive structures. The aim of this study was to investigate intensity-modulated radiotherapy's (IMRT) possibilites of either increasing, in a safe way, the dose to 50-60 Gy in case of macroscopic disease or decreasing the dose to organs at risk (OR) when treatment is given in an adjuvant setting. MATERIAL AND METHODS: The dosimetric charts of 14 patients irradiated to the PO region at the Department of Radiation Oncology, University Hospital of Liege, Belgium, in 2000 were analyzed in order to compare six-field conformal external-beam radiotherapy (CEBR) and five-beam IMRT approaches. Both CEBR and IMRT investigations were planned to theoretically deliver 60 Gy to the PO region in the safest way possible. Dose-volume histograms (DVHs) were calculated for clinical target volume (CTV), planning target volume (PTV), and OR. Student's t-test was used to compare the paired DVH data issued from CEBR and IMRT planning. RESULTS: The IMRT approach allowed to cover the PTV at a higher level as compared to CEBR. Using IMRT, the maximal dose to the spinal cord was reduced from 42.5 Gy to 26.2 Gy in comparison with CEBR (p < 0.00001). Doses to the kidneys were significantly reduced, with < 20% receiving >or= 20 Gy in the IMRT approach (p < 0.00001). Irradiation of digestive structures was not different, with < 25% receiving 35 Gy. Doses to the liver remained low regardless of the method used. CONCLUSION: At 60 Gy, IMRT is largely sparing the spinal cord and kidneys as compared to CEBR and represents an interesting approach not only for dose escalation up to 50-60 Gy (probably facilitating the radiochemotherapy approaches) but also in an adjuvant setting at lower doses. The dosimetric data of this study are in the same range as those published recently with a dynamic arc conformal approach.
Disciplines :
Radiology, nuclear medicine & imaging Oncology
Author, co-author :
Hermesse, Johanne ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
Devillers, Magali ; Centre Hospitalier Universitaire de Liège - CHU > Radiothérapie
Deneufbourg, Jean-Marie ; Université de Liège-ULg Médecine Sciences cliniques Chargé de cours > CHU Radiothérapie Oncologie Chef de service
Nickers, Philippe; Centre hospitalier universitaire de Liège - CHU- > Radiothérapie Oncologie Chef de clinique
Language :
English
Title :
Can intensity-modulated radiation therapy of the Paraaortic region overcome the problems of critical organ tolerance?
Alternative titles :
[fr] La radiothérapie par modulation d'intensité de la région para-aortique peut-elle résoudre les problèmes que pose l'épargne des organes à risque ?
Aoki T, Nagata Y, Mizowaki T, et al. Clinical evaluation of dynamic arc conformal radiotherapy for paraaortic lymph node metastasis. Radiother Oncol 2003;67:113-8.
Bogner L, Scherer J, Treutwein M, et al. Verification of IMRT: techniques and problems. Strahlenther Onkol 2004;180:340-50.
De Meerleer G, Vakaet L, De Gersem W, et al. Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer. Strahlenther Onkol 2004;180:136-43.
Eifel PJ, Winter K, Morris M, et al. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: an update of RTOG 90-01. Int J Radiat Oncol Biol Phys 2002;54:Suppl:1.
Greven M, Levenback C, Chao CKS, et al. Gynecology Cancer Working Group. Research Plan 2002-2006. Int J Radiat Oncol Biol Phys 2001;51:Suppl 2:58-9.
Grisby PW, Heydon K, Mutch DG, et al. Long-term follow-up of RTOG 92-10: Cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 2001;51:982-7.
Haie C, Pejovic MH, Gerbaulet A, et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 1988;11:101-12.
ICRU, International Commission on Radiation Units and Measurements, Report 50. Prescribing, recording, and reporting photon beam therapy. Washington: ICRU, 1993.
ICRU Report 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU Report 50). Washington: ICRU, 1999.
Lohr F, Dobler B, Mai S, et al. Optimization of dose distributions for adjuvant locoregional radiotherapy of gastric cancer by IMRT. Strahlenther Onkol 2003;179:557-63.
Portelance L, Chao KSC, Grisby PW, et al. Intensity-modulated radiation therapy reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 2001;51:261-6.
Rotman M, Pajak T, Choi K, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIa cervical carcinoma, ten-year treatment results of RTOG 79-20. JAMA 1995;274:387-93.
Saad AA, Lo SS, Han I, et al. Radiation therapy with or without chemotherapy for cervical cancer with periaortic lymph node metastasis. Int J Radiat Oncol Biol Phys 2002;54:Suppl:40.
Varia MA, Bundy BN, Deppe G, et al. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynaecologic Oncology Group study. Int J Radiat Oncol Biol Phys 1998;42:1015-23.
Willner J, Jost A, Baier K, et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 2003;179:548-56.
